Shared mechanisms of multimorbidity in COPD, atherosclerosis and type-2 diabetes: the neutrophil as a potential

Michael J Hughes1, Helen M McGettrick2, Elizabeth Sapey3

  • 1Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK mxh619@bham.ac.uk.

Insights

Common mechanisms link chronic obstructive pulmonary disease (COPD), type-2 diabetes mellitus (T2D), and atherosclerosis. This review explores shared pathways like inflammation and cellular aging, identifying potential therapeutic targets for multimorbidity.

Area of Science:

  • * Integrative biology and pathophysiology of chronic diseases.
  • * Focus on shared mechanisms in multimorbidity.

Background:

  • * Multimorbidity is rising, challenging current healthcare models.
  • * COPD, T2D, and atherosclerosis frequently co-occur, suggesting shared etiological factors beyond traditional risks.
  • * Neutrophilic inflammation is implicated in all three conditions, potentially linking them.

Purpose of the Study:

  • * To review the scientific evidence linking COPD, T2D, and atherosclerosis.
  • * To explore common pathogenic mechanisms including inflammation, cellular senescence, and phenotypic changes.
  • * To identify and evaluate emerging therapeutic strategies targeting these shared pathways.

Main Methods:

  • * Comprehensive literature review of current scientific evidence.
  • * Analysis of studies focusing on inflammation, cellular aging, and cellular processes (ROS, phenotypic changes).
  • * Synthesis of findings related to the pathogenesis of COPD, T2D, and atherosclerosis.

Main Results:

  • * Neutrophilic inflammation is a key shared mechanism in COPD, T2D, and atherosclerosis.
  • * Cellular senescence and altered cellular phenotypes are increasingly recognized as common contributors.
  • * Evidence suggests a systemic inflammatory milieu contributes to multimorbidity progression.

Conclusions:

  • * Inflammation and cellular aging represent unifying pathogenic mechanisms across COPD, T2D, and atherosclerosis.
  • * Targeting these shared pathways offers potential for novel therapeutic approaches in multimorbidity.
  • * Further research into underlying cellular biology is needed for effective multimorbid disease management.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.4K
Inflammation01:38

Inflammation

Overview
61.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
789
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K